Skip to main content
Clinical Trials/NCT04409717
NCT04409717
Completed
Not Applicable

Evaluation of the Long Term Efficacy of Endovascular Treatment of Type 2 Endoleaks

Centre Hospitalier Universitaire Dijon1 site in 1 country19 target enrollmentJanuary 1, 2020

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Abdominal Aortic Aneurysm
Sponsor
Centre Hospitalier Universitaire Dijon
Enrollment
19
Locations
1
Primary Endpoint
Recurrence rate of type II endoleaks treated with endovascular intervention
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

Endovascular treatment has become the first choice to repair abdominal aortic aneurym, but exposes patients to a risk of endoleaks. Although treatment of type 1 and 3 endoleaks has proven to prevent aneurysms from rupture, controversies remain about type 2 endoleaks. The investigators described the different techniques of type 2 endovascular repair, and their efficacy at short and long term..

Registry
clinicaltrials.gov
Start Date
January 1, 2020
End Date
May 26, 2020
Last Updated
5 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Eric STEINMETZ

Professor

Centre Hospitalier Universitaire Dijon

Eligibility Criteria

Inclusion Criteria

  • All patients treated for type II endoleaks by endovascular therapy

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Recurrence rate of type II endoleaks treated with endovascular intervention

Time Frame: 12 years

Secondary Outcomes

  • Type of type II endoleaks treatment(12 years)

Study Sites (1)

Loading locations...

Similar Trials